MICROTECH MED-B (02235) proposes electing Zheng Pan as an executive director.
MicroTech Medical-B (02235) announced that the board proposes electing Dr. Zheng Pan and Dr. Shi Yonghui as executive directors of the third board of directors, proposes electing Mr. Mao Shuo and Ms. Gao Yun as non-executive directors of the third board of directors, and authorizes the board to determine their remuneration.
MICROTECH MED-B (02235) announces that the board proposes electing Dr. Zheng Pan and Dr. Shi Yonghui as executive directors of the third board of directors, proposes electing Mr. Mao Shuo and Ms. Gao Yun as non-executive directors of the third board of directors, and authorizes the board to determine their remuneration.
The company held an employee representative assembly on October 27, 2026, at which Dr. Yu Fei was elected as the company's employee representative director, to form the third board of directors together with the directors elected at the extraordinary general meeting.
Ms. Liu Xiu, an executive director of the second board of directors, has notified the board that she will not seek re-election as an executive director in order to devote more time to matters related to the company's financial and risk control management. Ms. Liu Xiu will cease to serve as an executive director of the company from the date the third board of directors is elected at the extraordinary general meeting, and will continue to serve as the company's chief financial officer.
Dr. Yu Fei, an executive director of the second board of directors, has notified the board that, given that he was elected as the company's employee representative director on October 27, 2026, he will not seek re-election as an executive director. Dr. Yu Fei will cease to serve as an executive director of the company from the date the third board of directors is elected at the extraordinary general meeting.
The board proposes electing Dr. Li Lihua, Mr. He Jianchang, Ms. Wang Chunfeng and Dr. Cheng Hua as independent non-executive directors of the third board of directors, and authorizes the board to determine their remuneration.
Related Articles

HENG TAI (00197) Announces Annual Results: Net Loss of Approximately HK$232 million, Up 13.3% Year-on-Year; Trading Resumes on November 3

US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 5% as Apple Intelligence integrates with Alibaba's Qwen.
.png)
POLY XVERSE IT (00209): Tan Yanyan Appointed as Independent Non-Executive Director
HENG TAI (00197) Announces Annual Results: Net Loss of Approximately HK$232 million, Up 13.3% Year-on-Year; Trading Resumes on November 3

US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 5% as Apple Intelligence integrates with Alibaba's Qwen.

POLY XVERSE IT (00209): Tan Yanyan Appointed as Independent Non-Executive Director
.png)





